179 related articles for article (PubMed ID: 18708242)
1. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
[TBL] [Abstract][Full Text] [Related]
2. Expression of stem cell factor (SCF), a KIT ligand, in gastrointestinal stromal tumors (GISTs): a potential marker for tumor proliferation.
Hirano K; Shishido-Hara Y; Kitazawa A; Kojima K; Sumiishi A; Umino M; Kikuchi F; Sakamoto A; Fujioka Y; Kamma H
Pathol Res Pract; 2008; 204(11):799-807. PubMed ID: 18602222
[TBL] [Abstract][Full Text] [Related]
3. Absence of gene mutations in KIT-positive thymic epithelial tumors.
Tsuchida M; Umezu H; Hashimoto T; Shinohara H; Koike T; Hosaka Y; Eimoto T; Hayashi JI
Lung Cancer; 2008 Dec; 62(3):321-5. PubMed ID: 18486988
[TBL] [Abstract][Full Text] [Related]
4. KIT/stem cell factor expression in premalignant and malignant lesions of the colon mucosa in relationship to disease progression and outcomes.
Bellone G; Smirne C; Carbone A; Buffolino A; Scirelli T; Prati A; Solerio D; Pirisi M; Valente G; Nano M; Emanuelli G
Int J Oncol; 2006 Oct; 29(4):851-9. PubMed ID: 16964380
[TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors.
Uccini S; Mannarino O; McDowell HP; Pauser U; Vitali R; Natali PG; Altavista P; Andreano T; Coco S; Boldrini R; Bosco S; Clerico A; Cozzi D; Donfrancesco A; Inserra A; Kokai G; Losty PD; Nicotra MR; Raschellà G; Tonini GP; Dominici C
Clin Cancer Res; 2005 Jan; 11(1):380-9. PubMed ID: 15671569
[TBL] [Abstract][Full Text] [Related]
6. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance.
Boldrini L; Ursino S; Gisfredi S; Faviana P; Donati V; Camacci T; Lucchi M; Mussi A; Basolo F; Pingitore R; Fontanini G
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4101-8. PubMed ID: 15217946
[TBL] [Abstract][Full Text] [Related]
7. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.
Krasagakis K; Kruger-Krasagakis S; Eberle J; Tsatsakis A; Tosca AD; Stathopoulos EN
Dermatology; 2009; 218(1):37-43. PubMed ID: 19001805
[TBL] [Abstract][Full Text] [Related]
8. Co expression of SCF and KIT in gastrointestinal stromal tumours (GISTs) suggests an autocrine/paracrine mechanism.
Théou-Anton N; Tabone S; Brouty-Boyé D; Saffroy R; Ronnstrand L; Lemoine A; Emile JF
Br J Cancer; 2006 Apr; 94(8):1180-5. PubMed ID: 16570044
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the KIT/SCF in uveal melanoma does not translate into clinical efficacy of imatinib mesylate.
Hofmann UB; Kauczok-Vetter CS; Houben R; Becker JC
Clin Cancer Res; 2009 Jan; 15(1):324-9. PubMed ID: 19118061
[TBL] [Abstract][Full Text] [Related]
10. Merkel cell carcinoma: evaluation of KIT (CD117) expression and failure to demonstrate activating mutations in the C-KIT proto-oncogene - implications for treatment with imatinib mesylate.
Swick BL; Ravdel L; Fitzpatrick JE; Robinson WA
J Cutan Pathol; 2007 Apr; 34(4):324-9. PubMed ID: 17381803
[TBL] [Abstract][Full Text] [Related]
11. The dermal stem cell factor and c-kit are overexpressed in melasma.
Kang HY; Hwang JS; Lee JY; Ahn JH; Kim JY; Lee ES; Kang WH
Br J Dermatol; 2006 Jun; 154(6):1094-9. PubMed ID: 16704639
[TBL] [Abstract][Full Text] [Related]
12. KIT mutations induce intracellular retention and activation of an immature form of the KIT protein in gastrointestinal stromal tumors.
Tabone-Eglinger S; Subra F; El Sayadi H; Alberti L; Tabone E; Michot JP; Théou-Anton N; Lemoine A; Blay JY; Emile JF
Clin Cancer Res; 2008 Apr; 14(8):2285-94. PubMed ID: 18413817
[TBL] [Abstract][Full Text] [Related]
13. Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer.
Tamborini E; Bonadiman L; Negri T; Greco A; Staurengo S; Bidoli P; Pastorino U; Pierotti MA; Pilotti S
Clin Cancer Res; 2004 Dec; 10(24):8214-9. PubMed ID: 15623596
[TBL] [Abstract][Full Text] [Related]
14. Early myeloid cells expressing c-KIT isoforms differ in signal transduction, survival and chemotactic responses to Stem Cell Factor.
Young SM; Cambareri AC; Odell A; Geary SM; Ashman LK
Cell Signal; 2007 Dec; 19(12):2572-81. PubMed ID: 17855052
[TBL] [Abstract][Full Text] [Related]
15. Molecular and biochemical analyses of platelet-derived growth factor receptor (PDGFR) B, PDGFRA, and KIT receptors in chordomas.
Tamborini E; Miselli F; Negri T; Lagonigro MS; Staurengo S; Dagrada GP; Stacchiotti S; Pastore E; Gronchi A; Perrone F; Carbone A; Pierotti MA; Casali PG; Pilotti S
Clin Cancer Res; 2006 Dec; 12(23):6920-8. PubMed ID: 17145809
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs).
Negri T; Bozzi F; Conca E; Brich S; Gronchi A; Bertulli R; Fumagalli E; Pierotti MA; Tamborini E; Pilotti S
J Pathol; 2009 Jan; 217(1):103-12. PubMed ID: 18973210
[TBL] [Abstract][Full Text] [Related]
17. Expression of stem cell factor and c-kit in human malignant fibrous histiocytoma cell line (TNMY1).
Nakatani T; Marui T; Yamamoto T; Hitora T; Akisue T; Kawamoto T; Nagira K; Fujita I; Matsumoto K; Yoshiya S; Kurosaka M
Anticancer Res; 2003; 23(3B):2329-33. PubMed ID: 12894511
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes.
Liegl B; Hornick JL; Corless CL; Fletcher CD
Am J Surg Pathol; 2009 Mar; 33(3):437-46. PubMed ID: 19011564
[TBL] [Abstract][Full Text] [Related]
19. CD117+ small cell lung cancer lacks the asp 816-->val point mutation in exon 17.
Mojica WD; Saxena R; Starostik P; Cheney RT
Histopathology; 2005 Nov; 47(5):517-22. PubMed ID: 16242000
[TBL] [Abstract][Full Text] [Related]
20. Rare expression of KIT (CD117) in lymphomas: a tissue microarray study of 1166 cases.
Zimpfer A; Went P; Tzankov A; Pehrs AC; Lugli A; Maurer R; Terracciano L; Pileri S; Dirnhofer S
Histopathology; 2004 Oct; 45(4):398-404. PubMed ID: 15469479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]